Skip to content
Homepage Banner 1 D5
Homepage Banner 2 D5
Homepage Banner 3 D5
Homepage Banner 4 D5
Slide 1
Slide 2
Slide 3
Slide 4
Previous Arrow
Next Arrow

AI-powered analysis and insights for breakthrough ophthalmic therapies.

Unrivaled Expertise E1724618122352

to help you evaluate trial endpoints

Faster Accurate Decision Making E1724617665996

with real-time access to data and insights

Exceptional Responsiveness E1724617619416

for an unmatched customer experience

Over the past decade the Voxeleron team has assisted with numerous advanced image analyses, computer vision evaluations, and cross-platform standardization. Recently, iNebula has provided a functional, easy, and simple interface for us to share image data from 103 study patients with various stakeholders in our development plan. A system like this is invaluable when managing large image datasets.”

Header Logo

 

In partnering with Voxeleron, we are using the most intuitive and accurate common-platform OCT analysis methods available, which provides advantages that are directly passed along to our trial sponsors.”

Voiant Logo Color

Watch: How Allgenesis Uses Imaging, Biomarkers and Post-hoc Analysis in its Phase 2 DME Trial

Recent News

Learn About Ophthalmic Image Analysis In Clinical Trials

Join our free quarterly newsletter for the latest in advances in ophthalmic image analysis to help you optimize your clinical trial.